Events

Notificaciones De Seguridad De Campo acerca de Contact Detach G29 PCC, SureT G29, Confort PCC, Silhouette Paradigm, Quick-Set Paradigm

Según ALIMS (Agencija za lekove i medicinska sredstva), este evento ( notificaciones de seguridad de campo ) involucró a un dispositivo médico en Serbia que fue producido por Medtronic.

¿Qué es esto?

Las notificaciones de seguridad de campo son comunicaciones sobre acciones que se pueden estar tomando en relación con un producto que se encuentra en el mercado, enviadas por los fabricantes de dispositivos médicos o sus representantes. Estas notificaciones son principalmente para trabajadores de la salud, pero también para usuarios. Pueden incluir alertas y retiro de equipos.

Más información acerca de la data acá
  • Tipo de evento
    Field Safety Notice
  • Fecha de publicación del evento
    2017-03-10
  • País del evento
    Serbia
  • Fuente del evento
    ALIMSA
  • URL de la fuente del evento
    https://www.alims.gov.rs/ciril/2017/10/03/%D0%BE%D0%B1%D0%B0%D0%B2%D0%B5%D1%88%D1%82%D0%B5%D1%9A%D0%B5-%D0%BE-%D0%BF%D0%BE%D0%B2%D0%BB%D0%B0%D1%87%D0%B5%D1%9A%D1%83-%D0%BC%D0%B5%D0%B4%D0%B8%D1%86%D0%B8%D0%BD%D1%81%D0%BA%D0%BE%D0%B3-%D1%81-7/
  • Notas / Alertas
    Serbian data is current through February 2018. All of the data comes from ALIMS (Agencija za lekove i medicinska sredstva), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Serbia.
  • Notas adicionales en la data
  • Causa
    Medtronic got information about possible over-delivery of insulin that required medical intervention that occurred shortly after changing the infusion set. an investigation by the company revealed that this could be due to the fluid blocking the infusion set membrane during the preparation and filling process.

Device

Contact Detach G29 PCC, SureT G29, Confort PCC, Silhouette Paradigm, Quick-Set Paradigm
  • Modelo / Serial
    1) model MMT-378 – 5176788; 5177470; 2) model MMT-381 – 5144279; 5177471; 5179856; 3) model MMT-396 – 5093714; 5105646; 5122579; 5144546; 4) model MMT-397 – 5078283; 5078275; 5078296; 5088343; 5088350; 5088358; 5088655; 5093683; 5093689; 5097164; 5093706; 5097172; 5101210; 5105578; 5105574; 5108248; 5108249; 5108277; 5108276; 5122033; 5122036; 5122061; 5131577; 5131580; 5131588; 5131600; 5139845; 5143466; 5143472; 5143494; 5154323; 5154322; 5152592; 5162170; 5162163; 5165422; 5165425; 5176001; 5175990; 5173520 5) model MMT-399 – 5079023; 5079038; 5079047; 5079034; 5088361; 5088369; 5088372; 5093755; 5098085; 5098580; 5098576; 5101295; 5105511; 5105517; 5108382; 5108396; 5114616; 5114617; 5123575; 5123576; 5131653;5131664; 5131663; 5139848; 5139849; 5144221; 5146697; 5146721; 5146722; 5146723; 5146718; 5154342; 5154355; 5154361; 5164660; 5164659; 5164663; 5170875; 5170888; 6) model MMT-864 – 5152312; 5152313; 5167793; 5180450; 5184966; 5184967; 7) model MMT-874 – 5139034; 5170788; 5180068; 8) model MMT-886 – 5174594; 5180070
  • Manufacturer
    Medtronic

Manufacturer

Medtronic
  • Empresa matriz del fabricante (2017)
    Medtronic plc
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    ALIMSA